Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China · Delayed Price · Currency is CNY

4.500

+0.060 (1.35%)

Jun 9, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Intersegment Elimination	-658.25M	-	-	-	-
Industrial	2.49B	2.27B	2.46B	2.29B	2.86B
Industrial Growth	9.35%	-7.72%	7.57%	-19.97%	12.14%
Others	22.80M	36.31M	45.43M	32.37M	28.40M
Others Growth	-37.19%	-20.07%	40.36%	13.97%	14.83%
Medical Institutions	67.86M	64.22M	60.08M	51.78M	57.39M
Medical Institutions Growth	5.66%	6.90%	16.01%	-9.77%	50.66%
Commercial Business	1.13B	1.45B	1.69B	1.16B	162.38M
Commercial Business Growth	-22.15%	-14.31%	45.33%	617.36%	-65.61%
Total	3.05B	3.83B	4.26B	3.54B	3.11B
Total Growth	-20.31%	-10.26%	20.42%	13.79%	0.75%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	3.05B	3.83B	4.26B	3.54B	3.11B
China Growth	-20.31%	-10.26%	20.42%	13.79%	0.75%
Total	3.05B	3.83B	4.26B	3.54B	3.11B
Total Growth	-20.31%	-10.26%	20.42%	13.79%	0.75%

Source: S&P Global Market Intelligence.